ISSN: 2251-8363    eISSN: 2251-8819  
J Nephropathol. 2017;6(3):103-104.
doi:10.15171/jnp.2017.17
PMID: 28975086
PMCID: PMC5607967

Scopus id: 85019874039

Editorial

Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts

Azar Nickavar 1 * , Mahnaz Sadeghian 2

1 Department of Pediatric Nephrology, Iran University of Medical Sciences, Tehran, Iran
2 Department of Pediatric Gastroenterology, Iran University of Medical Sciences, Tehran, Iran
*Corresponding author: Azar Nickavar, Department of pediatric nephrology, Iran University of Medical Sciences, Tehran, Iran, Email: anickavar@yahoo.com

Implication for health policy/practice/research/medical education:

Renal involvement is the main predictive factor of long-term outcome in children with Henoch-Schönlein purpura (HSP) . Different immunosuppressive medications have been introduced for the treatment of severe HSP nephritis to prevent subsequent renal impairment. Therapeutic effect of mycophenolate mofetil and its implication have been discussed in this editorial article.  

Please cite this paper as: Nickavar A, Sadeghian M. Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts. 2017;6(3):103-104. DOI: 10.15171/jnp.2017.17.

First name
 
Last name
 
Email address
 
Comments
 
Security code





First published online: 04 Dec 2016
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract Page Views: 1944
PDF Downloads: 1906
Full Text Views: 0